Results 111 to 120 of about 165,954,653 (289)

Diode Laser Photocoagulation in the Treatment of Retinopathy of Prematurity

open access: yes, 2013
Purpose: To make a data analysis of cases with retinopathy of prematurity that underwent diode laser photocoagulation (DLPC) treatment. Material and Method: Files of 52 ROP cases treated with DLPC between November 2011 and November 2012 were ...
Hüseyin Yetik   +2 more
core   +1 more source

Prognostic models for predicting sight‐threatening retinopathy of prematurity in preterm infants: A systematic review

open access: yesActa Ophthalmologica, EarlyView.
Abstract To identify, describe and critically appraise studies developing and/or validating models for predicting sight‐threatening retinopathy of prematurity (ROP) in preterm infants undergoing screening in neonatal intensive care units. PubMed, Embase via Ovid, trial registers, and grey literature were searched from inception to 21 October 2025 ...
Stella Moutzouri   +7 more
wiley   +1 more source

Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists

open access: yes, 2018
Samiksha Fouzdar Jain,1 Helen H Song,2 Shaza N Al-Holou,2 Linda A Morgan,1 Donny W Suh1,2 1Ophthalmology Department, Children’s Hospital and Medical Center, Omaha, NE, USA; 2Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE,
Fouzdar Jain S   +4 more
core  

Childhood ocular safety after postnatal exposure to topical dexamethasone during retinopathy of prematurity screening

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Dexamethasone eye drops are being introduced off‐label to prevent progression of severe retinopathy of prematurity (ROP). We evaluated ophthalmologic outcomes in early childhood after postnatal topical dexamethasone exposure in pre‐term infants at a standardized follow‐up examination.
Mariya Petrishka‐Lozenska   +3 more
wiley   +1 more source

A case of retinopathy of prematurity treated by pattern scan laser photocoagulation

open access: yesClinical Ophthalmology, 2014
Satoshi Ota, Miho Nozaki, Shuichiro Hirahara, Tomoaki Hattori, Munenori Yoshida, Yuichiro Ogura Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan Abstract: We experienced a case of
Ota S   +5 more
doaj  

Fundoscopic evolution of premature newborns with retinopathy of prematurity treated with intravitreal antiangiogenics [PDF]

open access: yesRevista Brasileira de Oftalmologia
Objective: To determine the evolution of retinopathy of prematurity in patients treated with intravitreal antiangiogenics in the retina private practice. Methods: A retrospective descriptive observational case series study was conducted.
Camila Sofía Negrín   +4 more
doaj   +2 more sources

Current screening and treatments in retinopathy of prematurity in the US

open access: yes, 2016
Ana M Suelves, Julia P Shulman Department of Ophthalmology, New York Medical College, Valhalla, NY, USA Abstract: Retinopathy of prematurity (ROP) is a complex disease characterized by an aberrant developmental retinal angiogenesis in preterm infants ...
Shulman JP, Suelves AM
core  

THESS‐ROP study: Development of a prediction model for treatment‐warranted retinopathy of prematurity and external validation of postnatal weight‐gain‐based models in Greece

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To develop THESS‐ROP, a novel prediction model for treatment‐warranted retinopathy of prematurity (TW‐ROP) and compare its performance with four established models in a Greek cohort of consecutively screened preterm infants. Methods This ambispective cohort study included all 526 infants screened for ROP (2016–2022) at the 2nd ...
Stella Moutzouri   +6 more
wiley   +1 more source

Retinopathy of Prematurity and MicroRNAs

open access: yesBiomedicines
Retinopathy of Prematurity (ROP), a leading cause of blindness in preterm infants, arises from dysregulated angiogenesis and inflammation. Without timely intervention, ROP can progress to severe outcomes, including dense fibrovascular plaques and retinal detachment.
Albanese, Giuseppe Maria   +8 more
openaire   +4 more sources

Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy